R&D
Longevity studies in life sciences today
Longevity has been discussed for a while now in the context of life sciences and pharma - we take a look at what's new now with Anat Naschitz.
News
Windward raises $165m for TSLP drug, and other biofinancings
Recent biotech financings include nine-figure rounds for Windward Bio and Coultreon, with Vivacta, Kanvas, and Moleculent also raising funds.
News
Bayer plans filings for cardiac amyloidosis imaging agent
Armed with new phase 3 data, Bayer is preparing to file a PET imaging agent that could accelerate the diagnosis of cardiac amyloidosis.
News
CellCentric pockets $220m for blood cancer programme
CellCentric has raised $220 million in a Series D financing that will help fund pivotal trials of p300/CBP inhibitor inobrodib in multiple myeloma.
News
BioNTech winds down COVID jab manufacturing, shedding staff
BioNTech's plan to shed 22% of its workforce and stop COVID-19 vaccine production has earned it a rebuke from Germany's third-largest labour union.
Debates & Insights
News
Press Releases
Editor's Picks
Editor's Picks
